Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells.

Zauli, Giorgio

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. [electronic resource] - Circulation research Apr 2003 - 732-40 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1524-4571

10.1161/01.RES.0000067928.83455.9C doi


Actins--drug effects
Apoptosis Regulatory Proteins
Calcium--metabolism
Cell Movement--drug effects
Cells, Cultured
Chromones--pharmacology
Cyclooxygenase Inhibitors--pharmacology
Endothelium, Vascular--cytology
Enzyme Activation--drug effects
Enzyme Inhibitors--pharmacology
Humans
Membrane Glycoproteins--pharmacology
Morpholines--pharmacology
NG-Nitroarginine Methyl Ester--pharmacology
Nitric Oxide--metabolism
Nitric Oxide Synthase--antagonists & inhibitors
Nitric Oxide Synthase Type III
Nitrobenzenes--pharmacology
Phosphoinositide-3 Kinase Inhibitors
Phosphorylation--drug effects
Prostaglandins--metabolism
Pyrazoles--pharmacology
Serine--metabolism
Sulfonamides--pharmacology
TNF-Related Apoptosis-Inducing Ligand
Time Factors
Tumor Necrosis Factor-alpha--pharmacology
Up-Regulation